IE
GENE

Israel Englander’s Genetic Technologies Ltd. GENE Stock Holding History

Israel Englander’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,124
Closed -$25K – 7222
2022
Q3 		$25K Buy
4,124
+1,099
+36% +$8.02K ﹤0.01% 6406
2022
Q2 		$17K Buy
+3,025
New +$21.9K ﹤0.01% 6536
2022
Q1 		– Sell
-4,338
Closed -$41K – 7699
2021
Q4 		$41K Buy
4,338
+898
+26% +$11.5K ﹤0.01% 6519
2021
Q3 		$53K Buy
+3,440
New +$59K ﹤0.01% 6566
2015
Q3 		– Sell
-3,427
Closed -$208K – 3799
2015
Q2 		$208K Buy
3,427
+705
+26% +$59.1K ﹤0.01% 3035
2015
Q1 		$287K Buy
+2,722
New +$223K ﹤0.01% 3065

Other funds holding GENE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Israel Englander's GENE Position: Q4 2022 in Review

Israel Englander sold out of Genetic Technologies Ltd. (GENE) in Q4 2022, closing a stake of 4,124 shares — an estimated $25K sold.

Israel Englander first reported a position in GENE in Q1 2015 and held it in 6 quarters. The position peaked at $287K in Q1 2015. 8 funds tracked by Wall St. Rank hold GENE as of Q4 2022.

  • Israel Englander reported no remaining Genetic Technologies Ltd. position as of Q4 2022 after selling out during the quarter.
  • Israel Englander sold 4,124 Genetic Technologies Ltd. shares in Q4 2022, an estimated $25K.
  • Israel Englander first reported a position in Genetic Technologies Ltd. in Q1 2015 and held it in 6 quarters.
  • Israel Englander's Genetic Technologies Ltd. position peaked at $287K in Q1 2015.
  • 8 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.